GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Aveanna Healthcare Holdings Inc (NAS:AVAH) » Definitions » Peter Lynch Fair Value

Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) Peter Lynch Fair Value : N/A (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aveanna Healthcare Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Aveanna Healthcare Holdings's Peter Lynch Fair Value or its related term are showing as below:



AVAH's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.345
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Aveanna Healthcare Holdings Peter Lynch Fair Value Historical Data

The historical data trend for Aveanna Healthcare Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aveanna Healthcare Holdings Peter Lynch Fair Value Chart

Aveanna Healthcare Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - -

Aveanna Healthcare Holdings Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aveanna Healthcare Holdings's Peter Lynch Fair Value

For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aveanna Healthcare Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Aveanna Healthcare Holdings's Price-to-Peter-Lynch-Fair-Value falls into.



Aveanna Healthcare Holdings Peter Lynch Fair Value Calculation

Aveanna Healthcare Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *-0.201
=N/A

Aveanna Healthcare Holdings's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.20.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Aveanna Healthcare Holdings  (NAS:AVAH) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Aveanna Healthcare Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=2.80/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aveanna Healthcare Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Aveanna Healthcare Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Aveanna Healthcare Holdings (Aveanna Healthcare Holdings) Business Description

Traded in Other Exchanges
N/A
Address
400 Interstate North Parkway SE, Suite 1600, Atlanta, GA, USA, 30339
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. HHH segment provides home health, hospice, and specialty program services to elderly populations seeking compassionate care and assistance with activities of daily living in the home. MS segment provides needed supplies to patients requiring enteral nutrition services or respiratory care.
Executives
Deborah Stewart officer: SVP, Chief Accounting Officer 400 INTERSTATE NORTH PARKWAY SE, ATLANTA GA 30339
Matthew Buckhalter officer: See Remarks 400 INTERSTATE NORTH PARKWAY SE, SUITE 1600, ATLANTA GA 30339
Victor F Ganzi director
David Afshar officer: Chief Financial Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Patrick A. Cunningham officer: Chief Compliance Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Edwin C. Reisz officer: Chief Administrative Officer C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE STE 1600, ATLANTA GA 30339
Jeff Shaner officer: Chief Operating Officer 3350 RIVERWOOD PARKWAY SUITE 1400, ATLANTA GA 30339
Tony Strange director, officer: Chief Executive Officer 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Rodney D Windley director, officer: Executive Chairman 3 HUNTINGTON QUADRANGLE 2S, MELVILLE NY 11747
Steven E Rodgers director
Erica Schwartz director 400 INTERSTATE N. PARKWAY SE, SUITE 1600, C/O AVEANNA HEALTHCARE HOLDINGS INC., ATLANTA GA 30339
Bcip Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Whitney Strategic Partners Vii, L.p. 10 percent owner 130 MAIN STREET, NEW CANAAN CT 06840
Bcip T Associates Iv-b (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bcip T Associates Iv (us), L.p. 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116